Literature DB >> 2718390

The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression.

A Sanchez1, M P Kiley, B P Holloway, J B McCormick, D D Auperin.   

Abstract

Genomic and messenger RNAs of a Zaire strain of Ebola virus were cloned, and inserts specific for the nucleoprotein gene were isolated and sequenced. The nucleoprotein gene is located proximal to the 3' end of the genome and is preceeded by a putative leader sequence. The gene begins with the transcriptional start site sequence 3'-UACUCCUUCUAAUU..., and ends with the polyadenylation site sequence 3'-... UAAUUCUUUUUU. The predicted coding region is 2217 bases in length and encodes a protein that contains 739 amino acids, with a calculated molecular weight of 83.3 kDa. The protein has an approximate net charge of -30 and can be divided into a hydrophobic N-terminal half and a hydrophilic and highly acidic C-terminal half. An in vitro transcript, generated from plasmid DNA containing the entire coding region, directs the synthesis of authentic nucleoprotein in a rabbit reticulocyte lysate system. The genomic organization and transcriptional signals of Ebola are similar to those of other nonsegmented, negative-strand RNA viruses, but nucleic acid or amino acid sequence comparisons indicate a lack of similarity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2718390     DOI: 10.1016/0042-6822(89)90354-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Functional mapping of the nucleoprotein of Ebola virus.

Authors:  Shinji Watanabe; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

2.  Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide?

Authors:  S Becker; H Feldmann; C Will; W Slenczka
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

3.  Immunofluorescence method for detection of Ebola virus immunoglobulin g, using HeLa cells which express recombinant nucleoprotein.

Authors:  M Saijo; M Niikura; S Morikawa; I Kurane
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

4.  The structure of the C-terminal domain of the Zaire ebolavirus nucleoprotein.

Authors:  Paulina J Dziubańska; Urszula Derewenda; Jeffrey F Ellena; Daniel A Engel; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-08-29

5.  Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins.

Authors:  M Saijo; M Niikura; S Morikawa; T G Ksiazek; R F Meyer; C J Peters; I Kurane
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Detection of Ebola viral antigen by enzyme-linked immunosorbent assay using a novel monoclonal antibody to nucleoprotein.

Authors:  M Niikura; T Ikegami; M Saijo; I Kurane; M E Miranda; S Morikawa
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Authors:  Michael Weik; Jens Modrof; Hans-Dieter Klenk; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.

Authors:  A Sanchez; S G Trappier; B W Mahy; C J Peters; S T Nichol
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

9.  Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein.

Authors:  C Will; E Mühlberger; D Linder; W Slenczka; H D Klenk; H Feldmann
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Ebola protein analyses for the determination of genetic organization.

Authors:  L H Elliott; A Sanchez; B P Holloway; M P Kiley; J B McCormick
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.